AtriCure, Inc. develops, manufactures, and sells devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, the Asia-Pacific, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, a single-use disposable RF products for the treatment of cardiac arrhythmias; cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; and EPi-Sense Systems, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation. It also provides cryoSPHERE probe, which provides temporary pain relief by applying cryothermic energy to targeted intercoastal peripheral nerves in the ribcage; AtriClip System, an implantable device coupled to a single-use disposable applier; LARIAT System, a solution for soft-tissue closure; Lumitip dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; and Subtle Cannula's to support access for EPi-Sense catheters. In addition, the company sells various reusable cardiac surgery instruments. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.

AtriCure Inc.

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Atricure (ATRC – Research Report), Wave Life Science...

Analysts Offer Insights on Healthcare Companies: Atricure (ATRC), Wave Life Sciences (WVE) and Arcellx Inc (ACLX)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Atricure (ATRC – Research Report) and Boston Scienti...

Analysts Offer Insights on Healthcare Companies: Atricure (ATRC) and Boston Scientific (BSX)

Atricure ( ($ATRC) ) has provided an update. On January 9, 2026, AtriCure amended and extended its asset-based revolving credit facility with JPMor...

Market Cap	$1.80B	P/E Ratio	N/A
52W High	$43.18	52W Low	$28.29
Div Yield	N/A	Payout Ratio	N/A
EPS Growth 3Y	-41.9%	52W Position	63.3%
Overall Score	49	Value Score	60
Quality Score	60	Technical Score	27

EPS Current Est	$-0.2	EPS Next Est	$-0.02
EPS Growth Est	N/A	DPS Growth 3Y	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	ATRC	$37.72	+2.43%	496.75K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	ATRC	$37.72	+2.4%	496.75K
3
4
5
6

ATRC

ATRC

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get AtriCure Inc. Data in Excel

Get AtriCure Inc. Data in Excel